Cookie-Einstellungen
     
 
 
新闻
SYNFACTS | SYNFACT of the Month 2020-04-14

Caged Aptamers for Improved Cancer Imaging

Contributors: Dirk Trauner, Alexander J. E. Novak

Zhou F, Fu T, Huang Q, Kuai H, Mo L, Liu H, Wang Q, Peng Y, Han D, Zhao Z. * Fang X. * Tan W. * Hunan University, Changsha, Institute of Chemistry, Chinese Academy of Sciences, Beijing, University of Chinese Academy of Sciences, Hangzhou and Shanghai Jiao Tong University, P. R. of China

Hypoxia-Activated PEGylated Conditional Aptamer/Antibody for Cancer Imaging with Improved Specificity

J. Am. Chem. Soc. 2019;
141: 18421-18427


Key Words

aptamers - caging - cancer - azobenzenes - imaging

i_t133_s1_10-1055_s-0039-1691632.jpeg


Significance

Aptamers and antibodies are widely used as probes in tumor imaging. Recognition of the tumor by aptamers is based on overexpression of their targets in cancer cells, not target exclusivity. Here, the authors present a strategy to increase the specificity of aptamers by designing a conditional aptamer. Upon exposure to the tumor microenvironment the aptamer is liberated and able to bind its target, thus leading to higher recognition selectivity.


Comment

The authors conjugated an azobenzene-linked PEG5000 chain as a steric blocking group to the aptamer XQ-2d. The azobenzene functions as a redox-sensitive caging unit. When exposed to hypoxia in the tumor microenvironment the azobenzene is cleaved, liberating the ­active aptamer close to the tumor. The authors demonstrate that this strategy can also be applied to antibodies.

SYNFACTS

阅读SYNFACTS更多论文,请点击这里

5e8557f47a26c.jpg